These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway. Mao MH; Huang HB; Zhang XL; Li K; Liu YL; Wang P Biomed Pharmacother; 2018 Nov; 107():1093-1103. PubMed ID: 30257321 [TBL] [Abstract][Full Text] [Related]
8. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity. Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010 [TBL] [Abstract][Full Text] [Related]
9. Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro. Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U Jpn J Cancer Res; 2000 May; 91(5):534-42. PubMed ID: 10835499 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle. Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905 [TBL] [Abstract][Full Text] [Related]
11. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy. Luo Y; Chen X; Downs TM; DeWolf WC; O'Donnell MA J Immunol; 1999 Feb; 162(4):2399-405. PubMed ID: 9973521 [TBL] [Abstract][Full Text] [Related]
12. Antigen-specific CD4 T cells are induced after intravesical BCG-instillation therapy in patients with bladder cancer and show similar cytokine profiles as in active tuberculosis. Elsäßer J; Janssen MW; Becker F; Suttmann H; Schmitt K; Sester U; Stöckle M; Sester M PLoS One; 2013; 8(9):e69892. PubMed ID: 24039703 [TBL] [Abstract][Full Text] [Related]
13. Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model. Yoshino T; Miyazaki J; Kojima T; Kandori S; Shiga M; Kawahara T; Kimura T; Naka T; Kiyohara H; Watanabe M; Yamasaki S; Akaza H; Yano I; Nishiyama H PLoS One; 2019; 14(1):e0209196. PubMed ID: 30608942 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of lymphocytic responses after treatment with Bacillus Calmette-Guerin and interferon-alpha 2b for superficial bladder cancer. Gan YH; Mahendran R; James K; Lawrencia C; Esuvaranathan K Clin Immunol; 1999 Feb; 90(2):230-7. PubMed ID: 10080835 [TBL] [Abstract][Full Text] [Related]
15. Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Patard JJ; Saint F; Velotti F; Abbou CC; Chopin DK Urol Res; 1998; 26(3):155-9. PubMed ID: 9694595 [TBL] [Abstract][Full Text] [Related]
16. Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells. Lattime EC; Gomella LG; McCue PA Cancer Res; 1992 Aug; 52(15):4286-90. PubMed ID: 1638541 [TBL] [Abstract][Full Text] [Related]
17. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein. Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882 [TBL] [Abstract][Full Text] [Related]
18. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. Sato Y; Bolzenius JK; Eteleeb AM; Su X; Maher CA; Sehn JK; Arora VK JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518683 [TBL] [Abstract][Full Text] [Related]
19. The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells. Cho MJ; Kim MJ; Kim K; Choi YW; Lee SJ; Whang YM; Chang IH Biochem Biophys Res Commun; 2019 Jan; 509(1):167-174. PubMed ID: 30579607 [TBL] [Abstract][Full Text] [Related]
20. Natural Killer Anti-Tumor Activity Can Be Achieved by Esteso G; Aguiló N; Julián E; Ashiru O; Ho MM; Martín C; Valés-Gómez M Front Immunol; 2021; 12():622995. PubMed ID: 33708215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]